Biotechnology
Tracking since May 20, 2026 · Latest signal May 29, 2026 · 58 matched data points · 18 unclear/no-match
Overall sentiment
Positive 66% (38)Negative 5% (3)Neutral 29% (17)Unclear 18 no-match
Daily sentiment
Claims (21)
Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.
Parent: BiotechnologyEntity: Mosquito genetic modificationImpact: negativeDate: May 29, 2026Target: The use of biotechnology to modify mosquitoes for targeting humans8 matched entries1 confirmed0 disputed7 neutral18 unclear
Parent: BiotechnologyEntity: mRNA imprintingImpact: positiveDate: Apr 20, 2026Target: mRNA imprinting6 matched entries6 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: DNA synthesisImpact: positiveDate: Apr 21, 2026 - Apr 22, 2026Target: The effectiveness and potential impact of the new DNA synthesis method.5 matched entries1 confirmed0 disputed4 neutral0 unclear
Parent: BiotechnologyEntity: mRNA imprintingImpact: positiveDate: Apr 20, 2026Target: The transcription apparatus can remotely control cytoplasmic post-transcriptional mechanisms through the action of dozens of proteins.5 matched entries5 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Sperm-specific potassium channel Slo3Impact: positiveDate: Apr 20, 2026Target: Intracellular zinc export during sperm capacitation regulates the function of the sperm-specific potassium channel Slo3.4 matched entries3 confirmed0 disputed1 neutral0 unclear
Parent: BiotechnologyEntity: mRNA imprintingImpact: positiveDate: Apr 20, 2026Target: mRNA imprinting allows the transcription apparatus to remotely control cytoplasmic post-transcriptional mechanisms through the action of dozens of proteins.4 matched entries4 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Eli Lilly and CompanySub-entity: Acquisition of Kelonia TherapeuticsImpact: positiveDate: Apr 20, 2026Target: Eli Lilly and Company's acquisition of Kelonia Therapeutics3 matched entries3 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: UniDesign computational frameworkImpact: positiveDate: Apr 21, 2026Target: The effectiveness of the UniDesign computational framework in engineering Cas9 variants.3 matched entries1 confirmed0 disputed2 neutral0 unclear
Parent: BiotechnologyEntity: DEER technologyImpact: positiveDate: Apr 20, 2026Target: DEER technology's effectiveness in quantifying supramolecular packing in amyloid fibrils2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Designer baby companiesImpact: negativeDate: Apr 24, 2026Target: The stability and viability of designer baby companies2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Eli LillySub-entity: Kelonia TherapeuticsImpact: positiveDate: Apr 20, 2026Target: Eli Lilly's acquisition of Kelonia Therapeutics for $3.25 billion2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: TLR4 receptorImpact: positiveDate: Apr 19, 2026Target: Inhibiting the TLR4 receptor can protect against hypothalamic inflammation2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Mitochondrial modulationImpact: positiveDate: Apr 20, 2026Target: Modulating inter-mitochondrial contacts to increase membrane potential can mitigate blue light-induced mitochondrial dysfunction.2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: NeurobotsImpact: positiveDate: Apr 21, 2026Target: Neurobots are capable of self-organization and forming functional neural circuits.2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Programmed Cell DeathImpact: positiveDate: Apr 19, 2026Target: Programmed cell death's role in modifying neural circuits and influencing intrinsic behaviors2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: SImBA-SiQuAlImpact: positiveDate: Apr 21, 2026Target: SImBA-SiQuAl's effectiveness in phenotypic profiling of 3D microtumours2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Virtual Biology InitiativeImpact: positiveDate: May 1, 2026Target: The Virtual Biology Initiative's funding and its impact on scientific progress.2 matched entries1 confirmed0 disputed1 neutral0 unclear
Parent: BiotechnologyEntity: Spider silk protein evolutionImpact: positiveDate: Apr 20, 2026Target: The study's contribution to understanding spider silk protein evolution2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Spider silk proteinsImpact: positiveDate: Apr 20, 2026Target: The study's contribution to understanding spider silk proteins' evolution2 matched entries2 confirmed0 disputed0 neutral0 unclear
Parent: BiotechnologyEntity: Amyloid FibrilsImpact: positiveDate: Apr 20, 2026Target: The effectiveness of DEER spectroscopy in characterizing amyloid fibril structures.2 matched entries0 confirmed0 disputed2 neutral0 unclear
Parent: BiotechnologyEntity: Neural CircuitsImpact: positiveDate: Apr 19, 2026Target: Undead neurons can be integrated into neural circuits and modify specific behaviors.2 matched entries2 confirmed0 disputed0 neutral0 unclear